Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial
Abstract Irritable bowel syndrome (IBS) is the most common gastrointestinal disorder significantly decreasing patients’ lives of quality and placing huge economic burden on our society. Existing studies indicated that the therapeutic effects maintained for a period of time after the treatments were...
Guardado en:
Autores principales: | Liang Zheng, Weimin Lu, Qi Xiao, Yaoliang Lai, Heng Fan, Yuling Sun, Dawei Huang, Yuanyuan Wang, Zhen Li, Zhengyan Jiang, Xingxing Liu, Lijuan Zhang, Dongmei Zuo, Zhexing Shou, Qing Tang, Huisuo Huang, Yongqiang Yang, Zongxiang Tang, Jun Xiao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15c097a34cb24b229a7aa5256b436878 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Xiufang Cui, et al.
Publicado: (2021) -
Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
por: Róisín Ní Dhonnabháín, et al.
Publicado: (2021) -
The fecal mycobiome in patients with Irritable Bowel Syndrome
por: A. Das, et al.
Publicado: (2021) -
The role of inflammation in irritable bowel syndrome (IBS)
por: Ng QX, et al.
Publicado: (2018) -
Five personality dimensions in patients with irritable bowel syndrome
por: Alireza Farnam, et al.
Publicado: (2008)